EPTIS
BAM Logo

Suche einen Ringversuch (RV) in der Datenbank

Länder
Seite 2 von 3 (Treffer 21 bis 40 von 48)
ID
Land
Anbieter
Ringversuch
Zuletzt geändert
807218 Brazil QLM Inovações Tecnológicas QLM Inovações Tecnológicas Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] Interlaboratorial Program Test Mobile Phone [Comparação Interlaboratorial em Ensaio em telefone celular] 2024-10-18
Prüfeigenschaft (SAR)

1138638 Canada CMPT - Canadian Microbiology Proficiency Testing CMPT - Canadian Microbiology Proficiency Testing COVID-19 COVID-19 2024-01-23
Prüfeigenschaft (SARS CoV-2)
Ringversuchsbezeichnung (COVID-19)

1050992 France CTCB CTCB RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] 2023-05-24
Prüfeigenschaft (ARN SARS-CoV2 - cell culture supernatant)
Prüfobjekt (Detection of SARS-CoV2 RNA)
Ringversuchsbezeichnung (in Landessprache) (ARN SARS-CoV2 (virologie))
Ringversuchsbezeichnung (RNA SARS-CoV2 (virology))

1163321 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] Virus Genome Detection – Respiratory Virus Panel 2 for Multiplex Tests (432) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 2 für Multiplex Teste (432)] 2024-04-16
Prüfeigenschaft (influenza A and B viruses incl. avian influenza A viruses, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated))

1163304 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] Virus Genome Detection – Respiratory Virus Panel 1 for Multiplex Tests (431) [Virusgenom-Nachweis - Respiratorisches Virus-Panel 1 für Multiplex Teste (431)] 2024-04-16
Prüfeigenschaft (incl. avian influenza A viruses, parecho, parainfluenza, respiratory syncytial viruses (groups A and B) and SARS-CoV-2 (inactivated), respectively)

1163345 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] Virus Genome Detection – SARS-CoV-2 sequence analysis (417) [Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417)] 2024-04-16
Kommentar (Please note: Starting in 2024, only results of SARS-CoV-2 sequence analyses for SARS-CoV-2)
Prüfeigenschaft (Differentiation of SARS-CoV-2 variants with clinical relevance using whole genome sequencing)
Ringversuchsbezeichnung (in Landessprache) (Virusgenom-Nachweis - SARS-CoV-2 Sequenzanalyse (417))
Ringversuchsbezeichnung (Virus Genome Detection – SARS-CoV-2 sequence analysis (417))

1163338 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] Virus Genome Detection – SARS-CoV-2 (409) [Virusgenom-Nachweis - SARS-CoV-2 (409)] 2024-04-16
Prüfeigenschaft (The sample set contains defined samples with SARS-CoV-2 (full virus, inactivated) and, if necessary) (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2)
Ringversuchsbezeichnung (in Landessprache) (Virusgenom-Nachweis - SARS-CoV-2 (409))
Ringversuchsbezeichnung (Virus Genome Detection – SARS-CoV-2 (409))

1160040 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] Virus Antigen Detection – SARS-CoV-2 (Ag) (410) [Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410)] 2024-04-16
Kommentar (samples with antigen from SARS-CoV-2 (inactivated) and, if necessary, samples with antigen from human) (immunoassays for the detection of SARS-CoV-2 antigen. The interdisciplinary, non-profit)
Prüfeigenschaft (SARS-CoV-2 antigen)
Ringversuchsbezeichnung (in Landessprache) (Virusantigen-Nachweis - SARS-CoV-2 (Ag) (410))
Ringversuchsbezeichnung (Virus Antigen Detection – SARS-CoV-2 (Ag) (410))

1169419 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] Virus Immunology – SARS-CoV-2 (Ab) (416) [Virusimmunologie - SARS-CoV-2 (Ak) (416)] 2024-05-14
Prüfeigenschaft (Anti-SARS-CoV-2 total (without differentiation of IgG, IgA and IgM)) (Anti-SARS-CoV-2 IgG) (Anti-SARS-CoV-2 IgG avidity) (Anti-SARS-CoV-2 IgA) (Anti-SARS-CoV-2 IgM (not certified))
Ringversuchsbezeichnung (in Landessprache) (Virusimmunologie - SARS-CoV-2 (Ak) (416))
Ringversuchsbezeichnung (Virus Immunology – SARS-CoV-2 (Ab) (416))

907768 Germany Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Institut für Qualitätssicherung Lübeck (IfQ-Lübeck) Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] Antibodies against SARS-CoV-2 [Antikörper gegen SARS-CoV-2] 2021-11-25
Prüfeigenschaft (Anti-SARS-CoV-2 (NCP) IgG) (Anti-SARS-CoV-2 (S1) IgG)
Ringversuchsbezeichnung (in Landessprache) (Antikörper gegen SARS-CoV-2)
Ringversuchsbezeichnung (Antibodies against SARS-CoV-2)

437169 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340) [Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)] Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340) [Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)] 2024-04-16
Prüfeigenschaft (Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV) (Option for differentiaton between SARS-CoV-2, MERS-CoV and other human coronaviruses (samples which) (contain SARS-CoV-2 and MERS-CoV, repectively, are inactivated)
Ringversuchsbezeichnung (in Landessprache) (Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340))
Ringversuchsbezeichnung (Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340))

824901 Germany Reference Institute for Bioanalytics Reference Institute for Bioanalytics SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] SARS-CoV-2 Immunology [SARS-CoV-2 Immunologie] 2021-02-16
Prüfeigenschaft (Anti-SARS-CoV-2 IgG, Anti-SARS-CoV-2 IgA)
Ringversuchsbezeichnung (in Landessprache) (SARS-CoV-2 Immunologie)
Ringversuchsbezeichnung (SARS-CoV-2 Immunology)

1271562 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] Virus serology: SARS-CoV-2 [Vírus szerológia: SARS-CoV-2] 2024-10-08
Kommentar (The content of the scheme: SARS-CoV-2 antibody (IgG-, IgG-S, IgG-N, IgM, IgA, total antibody)
Prüfeigenschaft (Anti-SARS-CoV-2 total (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-S (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG-N (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgG (OD, S/CO, quantitative, evaluation)) (Anti-SARS-CoV-2 – IgM (OD, S/CO, quantitative, evaluation))
Ringversuchsbezeichnung (in Landessprache) (Vírus szerológia: SARS-CoV-2)
Ringversuchsbezeichnung (Virus serology: SARS-CoV-2)

1271523 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. POCT: SARS-CoV-2 [POCT: SARS-CoV-2] POCT: SARS-CoV-2 [POCT: SARS-CoV-2] 2024-10-08
Kommentar (The content of the scheme: SARS-CoV-2 antibody (IgG, IgM, total antibody) and antigen determination)
Prüfeigenschaft (Anti-SARS-CoV-2 total qualitative) (Anti-SARS-CoV-2 - IgG qualitative) (Anti-SARS-CoV-2 - IgM qualitative) (SARS-CoV-2 Antigen qualitative) (SARS-CoV-2 interpretation)
Ringversuchsbezeichnung (in Landessprache) (POCT: SARS-CoV-2)
Ringversuchsbezeichnung (POCT: SARS-CoV-2)

1271426 Hungary QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. QualiCont In Vitro Diagnostic Quality Control Nonprofit Ltd. Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] Virus nucleic acid determination: SARS-CoV-2 [Vírus nukleinsav meghatározás: SARS-CoV-2] 2024-11-25
Kommentar (amplification techniques (NAT) for qualitative determination of SARS-CoV-2 virus. Qualitative results are)
Ringversuchsbezeichnung (in Landessprache) (Vírus nukleinsav meghatározás: SARS-CoV-2)
Ringversuchsbezeichnung (Virus nucleic acid determination: SARS-CoV-2)

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] SARS-CoV-2, molecular detection [SARS-CoV-2, molecular detection] 2024-03-13
Prüfeigenschaft (SARS-CoV-2 virus)
Ringversuchsbezeichnung (in Landessprache) (SARS-CoV-2, molecular detection)
Ringversuchsbezeichnung (SARS-CoV-2, molecular detection)

1129430 Spain ielab ielab SARS-CoV-2 [SARS-CoV-2] SARS-CoV-2 [SARS-CoV-2] 2023-11-29
Prüfeigenschaft (SARS-CoV-2)
Ringversuchsbezeichnung (in Landessprache) (SARS-CoV-2)
Ringversuchsbezeichnung (SARS-CoV-2)

883284 Thailand Department of Medical Sciences PT provider (DMSc PT provider) Department of Medical Sciences PT provider (DMSc PT provider) SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] SARS-CoV-2 detection by Real-time RT-PCR [SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข)] 2024-01-09
Ringversuchsbezeichnung (in Landessprache) (SARS-CoV-2 ด้วยวิธี Real-time RT-PCR (สถาบันวิจัยวิทยาศาสตร์สาธารณสุข))
Ringversuchsbezeichnung (SARS-CoV-2 detection by Real-time RT-PCR)

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Prüfeigenschaft (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Prüfmethode (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-09-06
Prüfeigenschaft (SARS-CoV-2)
Prüfobjekt (Surface testing (swab rinsate) for SARS-CoV-2 molecular)

Seite 2 von 3 (Treffer 21 bis 40 von 48)
Haben Sie Fragen? Senden Sie uns eine E-Mail: eptis@bam.de.
Anwendungsversion: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5